Myeloablative conditioning and late complications in ARTEMIS-deficient SCID
ARTEMIS 缺陷 SCID 的清髓调理和晚期并发症
基本信息
- 批准号:9251366
- 负责人:
- 金额:$ 23.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-20 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAlkylating AgentsAllelesAntigen ReceptorsAntigensAreaAutoimmunityB-LymphocytesBone Marrow TransplantationBusulfanCell physiologyCellsChemotherapy-Oncologic ProcedureClinicalCodeCyclophosphamideDNA Double Strand BreakDNA RepairDNA Repair GeneDNA lesionDNA-PKcsDefectDentalDevelopmentDiseaseDouble Strand Break RepairEndocrineEngraftmentExhibitsFailureGene MutationGene RearrangementGenesGoalsGrowthHematopoietic Stem Cell TransplantationHumanHypersensitivityImmuneImmunologic Deficiency SyndromesImmunologicsImpairmentIndividualInheritedInvestigationIonizing radiationJ segment geneLIG4 geneLate EffectsLeadLymphocyteLymphoidMalignant NeoplasmsMature B-LymphocyteMonoclonal AntibodiesMorbidity - disease rateMutateMutationMyeloablative ChemotherapyNatural Killer CellsNonhomologous DNA End JoiningOrganPathway interactionsPatientsPhenotypePlayPredispositionProcessProteinsProto-Oncogene Protein c-kitRadiationRadiation ToleranceReceptor GeneRegimenReportingResearchRoleSevere Combined ImmunodeficiencySeveritiesT-LymphocyteTimeTissuesToxic effectTransplantation ConditioningV(D)J Recombinationartemiscell typechemotherapyconditioningcongenital immunodeficiencycurative treatmentscytotoxiccytotoxicityeffective therapyendonucleasehematopoietic cell transplantationimprovedinsightirradiationmortalitymouse modelmutantnull mutationpreventradiosensitivereceptorreconstitutionrepairedresponsesuccesstumorigenesis
项目摘要
PROJECT ABSTRACT
The vastly diverse antigen receptor genes are assembled from numerous V, D and J coding segments
via the lymphoid specific DNA rearrangement, V(D)J recombination. Defective V(D)J recombination impairs
lymphocyte development and thus, results in immunodeficiency. The non-homologous end joining (NHEJ)
pathway is required during V(D)J recombination by virtue of its role as one of the major DNA double strand
break (DSB) repair pathways. Mutations in nearly all of the NHEJ genes have been found in association with
human primary immunodeficiency syndromes. ARTEMIS is the most frequently mutated NHEJ gene and was
initially discovered in the radiation sensitive severe combined immunodeficiency syndrome, RS-SCID. NHEJ-
deficient patients can undergo hematopoietic cell transplantation to reconstitute T and B cell functions.
However, because NHEJ is critical for DSB repair in all cell types, conditioning regimens involving radiation
cause excessive tissue damage and can lead to mortality. ARTEMIS-deficient patients have been successfully
engrafted with T and B cells with myeloablative conditioning using alkylating agents. However, these patients
exhibit late complications including growth failure, endocrine deficiencies and dental abnormalities. The goals
of this proposal are to elucidate the mechanisms underlying the toxicities associated with myeloablative
conditioning with alkylating agents using our previously developed and characterized mouse models of NHEJ-
deficient SCID and to determine the efficacy of alternative conditioning regimens. The potential for late onset
tumorigenesis associated will also be examined. Together, these studies will provide mechanistic insight into
the causes of late toxicities in NHEJ-deficient primary immunodeficiencies and potentially lead to the
development of more effective therapies.
项目摘要
各种各样的抗原受体基因由许多V、D和J编码片段组装而成
通过淋巴特异性DNA重排,V(D)J重组。缺陷性V(D)J重组损害
淋巴细胞发育,从而导致免疫缺陷。非同源末端连接(NHEJ)
由于其作为主要DNA双链之一的作用,在V(D)J重组过程中需要一条途径
破坏(DSB)修复途径。几乎所有NHEJ基因的突变都被发现与
人类原发性免疫缺陷综合征。ARTEMIS是最常见的突变NHEJ基因,
最初发现于放射敏感性严重联合免疫缺陷综合征,RS-SCID。NHEJ-
缺陷型患者可进行造血细胞移植以重建T和B细胞功能。
然而,由于NHEJ对于所有细胞类型中的DSB修复都是至关重要的,因此涉及辐射的预处理方案,
造成过度的组织损伤并可能导致死亡。ARTEMIS缺陷患者已成功地
移植T和B细胞,并使用烷化剂进行清髓性调节。但这些患者
出现晚期并发症,包括生长障碍、内分泌缺陷和牙齿畸形。的目标
这一建议的目的是阐明与清髓性化疗相关的毒性的潜在机制,
使用我们先前开发和表征的NHEJ小鼠模型,
缺陷的SCID,并确定替代预处理方案的疗效。迟发性的可能性
还将检查相关的肿瘤发生。总之,这些研究将提供机械洞察力,
NHEJ缺陷型原发性免疫缺陷中晚期毒性的原因,并可能导致
开发更有效的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JoAnn Sekiguchi其他文献
JoAnn Sekiguchi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JoAnn Sekiguchi', 18)}}的其他基金
Molecular mechanisms of lung disease in ataxia telangiectasia
共济失调性毛细血管扩张性肺部疾病的分子机制
- 批准号:
8582506 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别:
Molecular mechanisms of lung disease in ataxia telangiectasia
共济失调性毛细血管扩张性肺部疾病的分子机制
- 批准号:
8204498 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别:
Roles of the Artemis nuclease in DNA repair and disease
Artemis 核酸酶在 DNA 修复和疾病中的作用
- 批准号:
8072925 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别:
Molecular mechanisms of lung disease in ataxia telangiectasia
共济失调性毛细血管扩张性肺部疾病的分子机制
- 批准号:
8040274 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别:
Molecular mechanisms of lung disease in ataxia telangiectasia
共济失调性毛细血管扩张性肺部疾病的分子机制
- 批准号:
8386672 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别:
Mechanism and regulation of DNA end processing in V(D)J recombination and repair
V(D)J重组和修复中DNA末端加工的机制和调控
- 批准号:
8116793 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别:
Roles of the Artemis nuclease in DNA repair and disease
Artemis 核酸酶在 DNA 修复和疾病中的作用
- 批准号:
6993660 - 财政年份:2005
- 资助金额:
$ 23.25万 - 项目类别:
Mechanism and regulation of DNA end processing in V(D)J recombination and repair
V(D)J重组和修复中DNA末端加工的机制和调控
- 批准号:
8097247 - 财政年份:2005
- 资助金额:
$ 23.25万 - 项目类别:
Mechanism and regulation of DNA end processing in V(D)J recombination and repair
V(D)J重组和修复中DNA末端加工的机制和调控
- 批准号:
8488394 - 财政年份:2005
- 资助金额:
$ 23.25万 - 项目类别:
Roles of the Artemis nuclease in DNA repair and disease
Artemis 核酸酶在 DNA 修复和疾病中的作用
- 批准号:
7555918 - 财政年份:2005
- 资助金额:
$ 23.25万 - 项目类别:
相似海外基金
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
- 批准号:
10374792 - 财政年份:2021
- 资助金额:
$ 23.25万 - 项目类别:
Elucidation and prevention of the mechanism of hepatic sinusoidal obstruction syndrome (SOS) induced by DNA alkylating agents
DNA烷化剂诱发肝窦阻塞综合征(SOS)机制的阐明和预防
- 批准号:
21K15255 - 财政年份:2021
- 资助金额:
$ 23.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
- 批准号:
10570900 - 财政年份:2021
- 资助金额:
$ 23.25万 - 项目类别:
Development of individualized therapy by elucidation of molecular mechanisms for hypermutation phenotype induced by treatment with alkylating agents in glioma
通过阐明神经胶质瘤中烷化剂治疗诱导的超突变表型的分子机制来开发个体化治疗
- 批准号:
18K09004 - 财政年份:2018
- 资助金额:
$ 23.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Reversing intrinsic cancer cell resistance to alkylating agents by histone deacetylase inhibition
通过组蛋白脱乙酰酶抑制逆转癌细胞对烷化剂的内在耐药性
- 批准号:
214657440 - 财政年份:2012
- 资助金额:
$ 23.25万 - 项目类别:
Research Grants
Rerouting alkylating agents to the mitochondria for cancer therapy
将烷化剂重新路由至线粒体用于癌症治疗
- 批准号:
247842 - 财政年份:2011
- 资助金额:
$ 23.25万 - 项目类别:
Studentship Programs
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8105413 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8271313 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8730259 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8676463 - 财政年份:2010
- 资助金额:
$ 23.25万 - 项目类别: